[The role of combined treatment of prostatic gland after biopsy of the prostate for an elevated PSA level].
Urologiia
; (6): 39-43, 2009.
Article
en Ru
| MEDLINE
| ID: mdl-20169722
Benign prostatic hyperplasia and prostatic cancer have a significant effect of men's health, quality of life and death rate. Recent researches propose algorithms for treatment of benign prostatic hyperplasia which help determine optimal management of the disease using either alpha-adrenoblocker or combined therapy basing on factors of progression risk. Molecular-genetic, biological investigations reveal pathological prosesses leading to onset of the above pathological conditions thus opening prospects for prophylaxis of both benign and malignant prostatic hyperplasia. Further studies will specify efficacy and safety of 5-alpha reductase inhibitors in prevention of prostatic cancer.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hiperplasia Prostática
/
Neoplasias de la Próstata
/
Sulfonamidas
/
Algoritmos
/
Antígeno Prostático Específico
/
Finasterida
/
Antagonistas Adrenérgicos alfa
/
Inhibidores Enzimáticos
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Aspecto:
Patient_preference
Límite:
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Revista:
Urologiia
Asunto de la revista:
UROLOGIA
Año:
2009
Tipo del documento:
Article
Pais de publicación:
Rusia